|
|
Volumn 3, Issue 7, 2013, Pages
|
|
Selumetinib shows promise in metastatic uveal melanoma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
MITOGEN ACTIVATED PROTEIN KINASE;
SELUMETINIB;
TEMOZOLOMIDE;
ARTICLE;
CELL PROLIFERATION;
DRUG EFFICACY;
GENE MUTATION;
HUMAN;
MELANOCYTE;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL (TOPIC);
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SIGNAL TRANSDUCTION;
TUMOR GROWTH;
UVEA MELANOMA;
|
|
EID: 85047656288
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2013-086 Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|